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Abstract
DNAAF1 (LRRC50) is a cytoplasmic protein required for dynein heavy chain assembly and cilia motility, and DNAAF1
mutations cause primary ciliary dyskinesia (PCD; MIM 613193). We describe four families with DNAAF1 mutations and
complex congenital heart disease (CHD). In three families, all affected individuals have typical PCD phenotypes. However, an
additional family demonstrates isolated CHD (heterotaxy) in two affected siblings, but no clinical evidence of PCD. We
identified a homozygous DNAAF1 missense mutation, p.Leu191Phe, as causative for heterotaxy in this family. Genetic
complementation in dnaaf1-null zebrafish embryos demonstrated the rescue of normal heart looping with wild-type human
DNAAF1, but not the p.Leu191Phe variant, supporting the conserved pathogenicity of this DNAAF1 missense mutation. This
observation points to a phenotypic continuum between CHD and PCD, providing new insights into the pathogenesis of iso-
lated CHD. In further investigations of the function of DNAAF1 in dynein arm assembly, we identified interactions with mem-
bers of a putative dynein arm assembly complex. These include the ciliary intraflagellar transport protein IFT88 and the
AAAþ (ATPases Associated with various cellular Activities) family proteins RUVBL1 (Pontin) and RUVBL2 (Reptin). Co-
localization studies support these findings, with the loss of RUVBL1 perturbing the co-localization of DNAAF1 with IFT88. We
show that RUVBL1 orthologues have an asymmetric left-sided distribution at both the mouse embryonic node and the
Kupffer’s vesicle in zebrafish embryos, with the latter asymmetry dependent on DNAAF1. These results suggest that
DNAAF1-RUVBL1 biochemical and genetic interactions have a novel functional role in symmetry breaking and cardiac
development.
Introduction
Congenital heart disease (CHD) is the most common congenital
defect affecting 0.5–0.8% of all live births (1). Complex forms of
CHD carry a high morbidity and mortality and are associated
with disorders of laterality. Situs solitus is the term used to de-
scribe a normal arrangement of body anatomy, whereas situs
inversus is the mirror image of this arrangement. A failure of
asymmetry of the unpaired organs is termed situs ambiguus or
heterotaxy, and is associated with major CHD. Heterotaxy is
rare, occurring in 1: 10,000 pregnancies (2), and the genetic aeti-
ology is complex. Mutations in more than 15 genes have been
described as causes of inherited forms of heterotaxy, but the
majority of cases (80%) are thought to be sporadic (3).
Isomerism refers to a defect in the anatomy of paired organs
that usually have distinct left and right forms, but in isomerism
are placed in a mirror image formation (4). Heterotaxy and later-
ality defects are frequent clinical features of ciliopathies, disor-
ders in the structure or function of cilia, especially those
affecting the motile cilia (5,6).
Cilia are small microtubule-based organelles that play sen-
sory roles responding to chemical, morphogenic and mechani-
cal stimuli, as well as roles in cell and fluid motility. The
majority of vertebrate cell types express a single immotile sen-
sory primary cilium characterised by an axonemal core of nine
microtubule doublets in a 9þ 0 arrangement. However, multiple
specialized motile cilia are present on differentiated epithelial
cell-types of the brain, respiratory tract and Fallopian tubes.
Axonemal cores of motile cilia consist of nine microtubular
doublets surrounding a central pair of microtubules in a 9þ 2 ar-
rangement. In motile cilia, inner and outer dynein motor ‘arms’
(IDA and ODA) are attached to the peripheral microtubules that
act as molecular motors to provide the force required for ciliary
motility (7,8). Radial spokes connect the outer microtubules to
the central pair to provide a signal transduction scaffold that
regulates peripheral motors from the centre (9,10). A further
type of specialized motile cilia are present at the embryonic
node, with a 9þ 0 microtubule structure. These nodal cilia are
involved in the creation of a leftward fluid flow at the embryonic
node, a key step in breaking left-right symmetry in the early
embryo (11).
In motile cilia, dynein arms are incorporated into the axo-
neme as pre-assembled building blocks, which requires preas-
sembly of the IDAs and ODAs in the cytoplasm and their
subsequent transport into the ciliary axoneme, although the
mechanism by which this occurs is not known. ODAs are re-
sponsible for maintaining ciliary beat frequency and IDAs are
required for normal waveform. There are species-specific differ-
ences in dynein arm composition, but human respiratory cilia
ODAs consist of a globular head domain (heavy chains HC beta
[DNAH11/DNAH9] and HC gamma [DNAH5]), intermediate do-
main (DNAI1, DNAI2) and a docking complex (CCDC114,
CCDC151, ARMC4, TTC25), involved in anchoring the complex to
the neighbouring microtubule doublet (8,12,13). Associated with
this complex are multiple light chains required for assembly,
stability and motility (7).
Primary ciliary dyskinesia (PCD; MIM 244400) is predomi-
nantly an autosomal recessive disorder of motile cilia with an
incidence of 1: 15,000. Impaired mucociliary clearance leads to a
disorder of the sinopulmonary tract, presenting as neonatal re-
spiratory distress, chronic respiratory tract infections, bronchi-
ectasis and sinusitis. The link between disorders of laterality
and PCD has been long-established. Situs inversus is present in
around 50% of individuals affected with PCD (termed
Kartagener syndrome), due to the role of nodal cilia in the crea-
tion of asymmetry at the embryonic node (11) CHD is also com-
mon in PCD, occurring in 3.5–6% of affected individuals (14).
The association between CHD and PCD is further supported by
the demonstration of ciliary dysfunction in a cohort of patients
with heterotaxy and complex CHD (15,16). Mutations in genes
encoding dynein assembly factors, radial spoke components,
components of the ODA and dynein regulatory complex have all
been shown to cause PCD.
DNAAF1 (also known as LRRC50) is a human PCD disease
gene (17,18) and affected individuals have combined ODA and
IDA defects (17). DNAAF1 is orthologous to ODA7 in
Chlamydomonas and was initially identified as a dynein assem-
bly factor, with mutations in ODA7 causing reduced ciliary beat
frequency and a block in outer dynein arm assembly (19,20).
Two different zebrafish dnaaf1/ mutants develop typical mo-
tile cilia defects that include pronephric cysts, and have ran-
domized heart jogging and abnormal polarity of the visceral
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organs in more than 50% of mutants (21,22). The dnaaf1 mutants
have ultrastructural abnormalities of the dynein arms (lacking
either ODA, or both IDA and ODA) and have misalignment of
the outer microtubules, indicating that the microtubular archi-
tecture in these mutants is unstable (21,23). In human respira-
tory cells with mutations in DNAAF1, specific dynein heavy,
intermediate and light chains (DNAH5, DNAH9, DNAI2 and
DNALI1) were absent from the ciliary axoneme (17), supporting
the function of DNAAF1 as a dynein assembly factor. However,
the possible mechanisms by which DNAAF1 mediates ODA pre-
assembly and targeting of dyneins to the axoneme is largely
unknown.
In this study, we present a series of families affected by mu-
tations in DNAAF1. Three families have typical PCD phenotypes
with a high co-morbidity of cardiac defects, but a fourth family
has isolated CHD (heterotaxy) in two affected siblings with no
clinical evidence of PCD. We interpret a homozygous DNAAF1
missense mutation as causative for heterotaxy in the fourth
family including by genetic complementation assays in a dnaaf1
null zebrafish model. We identify and confirm biochemical and
functional interactions of DNAAF1 with IFT88 and RUVBL1
(Pontin), representing novel members of a putative dynein as-
sembly complex. We also show that RUVBL1 has an early left-
handed asymmetric distribution at the mouse embryonic node,
and that this asymmetry at the Kupffer’s vesicle in zebrafish
embryos is dependent on DNAAF1. These results expand the
functional roles of RUVBL1 to include symmetry-breaking and
cardiac development.
Results
Clinical features and genotype-phenotype correlations
Whole exome sequencing (WES) was performed in three sepa-
rate centres as part of studies to determine the genetic basis of
CHD and PCD (Leeds Institute of Biomedical and Clinical
Sciences, UCL Great Ormond Street Institute of Child Health and
the Leeds Genetics Laboratory). This identified putative disease-
causing mutations in DNAAF1 in four families with complex
congenital heart disease, with or without a clinical diagnosis of
PCD (Fig. 1A–D). All four families are from consanguineous
Pakistani ethnic backgrounds, living in the UK.
Family A has two children affected with complex CHD
(Fig. 1A). The affected male child II: 1 has complete atrioventric-
ular septal defect (AVSD) with significant AV valve regurgita-
tion, double outlet right ventricle (DORV), pulmonary atresia,
right atrial isomerism and right pulmonary artery stenosis. An
initial Blalock-Taussig shunt and a subsequent bidirectional
cavopulmonary shunt has been performed. His affected sibling
II: 2 has heterotaxy, described as dextrocardia, right atrial isom-
erism with a left-sided liver, right-sided stomach and right-
sided polysplenia. There is DORV, with the pulmonary artery to
the right and the aorta to the left. The aortic arch is rightward,
and there is a common atrium. Both ventricles are small and
there is a large inlet ventricular septal defect (VSD) and severe
subpulmonary stenosis. This child has had a Glenn shunt per-
formed. Neither of the affected individuals suffered from neo-
natal respiratory distress, recurrent chest infections, chronic
cough or chronic nasal symptoms. II: 1 has had recurrent epi-
sodes of otitis media. Their reduced exercise tolerance has been
ascribed to CHD. They are non-dysmorphic and have normal
learning.
Family B has three of six children confirmed as affected with
PCD, with a fourth child (II: 5) who died aged 2 months of car-
diac complications before a presumptive diagnosis of PCD could
be confirmed (Fig. 1B). Diagnosis of PCD in the surviving chil-
dren was made in the clinical setting following low nitric oxide
(NO) measurements and typical respiratory features of PCD
along with the observation of completely static nasal cilia ob-
served by high speed video imaging (0Hz ciliary beat frequency).
Individual II: 1 had an NO level of 40 ppb (10 nl/min). Diagnostic
transmission electron microscopy (TEM) analysis of the cilia
was abnormal in the three siblings II: 1, II: 4 and II: 6, showing
the absence of ciliary outer dynein arms in 84%, 92% and 100%
of cilia cross-sections respectively accompanied by occasionally
absent inner dynein arms (affecting 21, 22 and 30% of cross-
sections, respectively). The oldest child II: 1 has PCD with nor-
mal situs whilst the other two affected surviving children (II: 4,
II: 6) both have situs inversus with asplenia and a cardiac defect
of right atrial isomerism (RAI). In addition to RAI, II: 4 has the
most severe phenotype and is on home oxygen affected with
AVSD, pulmonary stenosis and anomalous pulmonary venous
drainage. Cardiac surgery was performed in early infancy con-
sisting of a Blalock-Taussig shunt aged 3 days, a bilateral-
directional Glenn shunt procedure at 2 years old and comple-
tion of total cavopulmonary connection aged 6. In addition to
RAI, II: 6 also has dextrocardia (azygous vein to left sided supe-
rior vena cava) and anomalous pulmonary venous drainage, but
no intervention was yet required. Deceased child II: 5 was af-
fected with RAI and the same multiple cardiac defects as II: 4,
but died aged 2 months of cardiac complications before a pre-
sumptive diagnosis of PCD could be confirmed.
Family C consists of a single male affected with clinically
confirmed PCD (Fig. 1C). He has dextrocardia, longstanding otitis
media and asthenospermia.
In Family D, two siblings are affected (Fig. 1D). The first
(II: 1) had suffered from neonatal respiratory distress and per-
sistent rhinorrhea from birth. He also had situs inversus, dex-
trocardia, congenitally-corrected transposition of the great
vessels, perimembranous ventricular septal defect (VSD) and
tricuspid regurgitation. Nasal ciliary brushing confirmed a di-
agnosis of PCD with static cilia, and a lack of ODA and IDA.
The second (II: 2) had a history of chronic cough, static cilia as
observed by high-speed videomicroscopy, and absent ODA
and IDA identified by TEM. This affected individual had no
history of cardiac disease.
Whole exome sequencing identifies DNAAF1mutation
as a cause of isolated heterotaxy
Whole exome sequencing (WES) was performed in all four fami-
lies. Family A was screened at the Leeds Institute of Biomedical
and Clinical Sciences, and Families B-D were screened as cases
referred to the diagnostic PCD services based at UCL Great
Ormond Street Institute of Child Health (Family B) and the
Leeds Genetics Laboratory (Family C and D). Similar variant call-
ing pipelines were followed in all analysis, as previously pub-
lished (24,25) and as described below for Family A.
Following alignment to the reference sequence (GRCh37)
and variant calling, variants were retained that were rare
(<1% MAF in ExAC, dbSNP, EVS and 3000 ethnically-matched
control exomes), functional (following removal of synony-
mous, non-coding, intronic and intergenic variants) and con-
sistent with inheritance pattern in the family (bialleic in
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affected individuals, but not biallelic in parents or unaffected
siblings). In Family A, a SNP array identified a 1Mb region of
homozygosity on chromosome 16. Only two variants re-
mained following filtering in Family A (Supplementary
Material, Table S1) and the variant with the highest pathoge-
nicity score, c.571C>T in DNAAF1 (NM_178452), also occurred
within the homozygous region. This variant predicts the mis-
sense mutation p.Leu191Phe in DNAAF1. Pathogenic variants
were not identified in any other known PCD genes. CNV analy-
sis was performed on exome data in Family A using the
ExomeDepth program, but no pathogenic CNVs were identi-
fied following removal of common variation. The c.571C>T
mutation was confirmed by Sanger sequencing and was ho-
mozygous in both patients and heterozygous in their mother
(paternal DNA was not available for testing; Fig. 1E and F). The
c.571C>T (p.Leu191Phe) missense mutation was extremely
rare amongst healthy individuals. It was not present in the
ExAC or gnomAD databases and only two heterozygotes were
present in 3000 ethnically-matched control samples. A further
19 patients affected with heterotaxy were investigated for mu-
tations in DNAAF1, but no further pathogenic mutations were
identified. The p.Leu191Phe mutation in Family A falls within
a region of leucine-rich repeat (LRR) domains in DNAAF1 and
affects a highly conserved leucine residue (Fig. 1I).
Figure 1. Segregation and location of DNAAF1 mutations in PCD and CHD families: (A–D) Pedigrees of families A–D where shading in the upper left quadrant indicates a
diagnosis of PCD and shading in the upper right quadrant indicates a diagnosis of CHD. (E) Integrative Genomics Viewer (IGV) readout with aligned whole-exome se-
quence reads shown in grey, indicating (in red) the DNAAF1 variant c.571C>T, which is homozygous in both affected individuals of Family A. (F) Electropherograms of
individuals in Family A showing (i) the mother of affected individuals II: 1 and II: 2, showing the variant in heterozygous form, (ii) affected male II: 1 and (iii) affected
male II: 2, showing the variant in homozygous form. The DNAAF1 variant is marked with blue shading. (G) IGV readout of whole-genome sequencing reads in Family D,
showing a homozygous deletion of 7.9 kilobases in DNAAF1, corresponding to an absence of aligned reads spanning chr16: 84, 193, 165–84, 201, 105. (H) Genomic
Sanger sequencing assay to show the breakpoints of a homozygous multi-exon deletion of 7940 bases in DNAAF1 (chr16[GRCh37]: g84193166_8201104del) for Family D.
(I) Position of mutations (red arrowheads) in the DNAAF1 gene (top) and protein (bottom), showing newly described mutations. The c.571C>T p.Leu191Phe mutation
associated with isolated heterotaxy occurs in the leucine-rich repeat (LRR) protein domain. “CC” indicates a single coiled-coil domain and “Pro-rich” indicates a region
of compositional bias.
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In Family B, heterozygous frameshift mutations in DNAAF1
were identified: c.281delA predicted to cause the frameshift
change p.Lys95Asnfs*14, and c.1484delC predicted to cause the
frameshift change p.Pro495Glnfs*40 (Fig. 1B). These mutations
segregated with disease in all the available family members and
were confirmed by Sanger sequencing. Both variants were
absent the ExAC or gnomAD databases. The affected individual
in Family C shared the same DNAAF1 mutation c.1484delC
(p.Pro495Glnfs*40) in the homozygous state, which was also
confirmed by Sanger sequencing (Fig. 1C). WES data suggest
that this mutation appears to be carried on a common disease
haplotype for Family B and C which both share a Pakistani eth-
nic origin.
Both affected individuals in Family D shared a homozygous
multi-exon deletion of 7940 bases in DNAAF1 (chr16[GRCh37]:
g84193166_8201104del). This deletion was identified from
exome data following the observation that no sequence reads
had mapped to the targeted exons (Fig. 1G). Breakpoints were
subsequently identified by whole genome sequencing (WGS),
and use of a breakpoint-spanning Sanger sequencing assay con-
firmed the presence and zygosity of the deletion in both af-
fected siblings (Fig. 1H).
Investigation of PCD in Family A
Investigations were performed to identify or refute a PCD phe-
notype in Family A. NO measurements in individual II: 1
showed a level of 254 ppb (63 nl/min) in the right nostril (normal
range) and 121 ppb (30 nl/min) in left nostril (low, but nostril
blocked by upper respiratory tract infection; ambient level of 17
ppb). Ciliary beat frequency for individual II: I was 8.7Hz (SD
2.2Hz), within the normal range, compared to 9.1Hz (SD 2.1Hz)
in a control sample taken concurrently. Video microscopy of na-
sal epithelial cells in individual II: 1 identified a sparsely ciliated
epithelium. Cilia effectively cleared surrounding debris, with
some thick mucus impeding the cilia beat in places. There was
a mixed beat pattern with some slow, dyskinetic and static
patches. This sample was collected concurrently as a sample
from a healthy control, and video microscopy was performed af-
ter the transport of the samples at room temperature for several
hours. The control sample had long, well-ciliated strips of
epithelium and the cilia were seen effectively clearing the sur-
rounding debris. The ciliary beat was mostly coordinated, but
not recorded as entirely normal because it was also mixed in
places with some slow, dyskinetic and static patches (see
Supplementary Movies). In affected individual II: 1, only 10 cili-
ary cross-sections could be assessed by TEM, but these all
showed normal ODA and IDA to be present. Overall, there was
no evidence to support a diagnosis of PCD in individual II: 1
from Family A on clinical testing. Parental consent for ciliary
brushings was not given for individual II: 2 in Family A.
Genetic complementation of heart looping defects in
dnaaf1/ zebrafish embryos by wild-type but not
p.Leu191Phe mutant DNAAF1
dnaaf1/ (dnaaf1hu255h) mutant zebrafish, with a T>A point mu-
tation creating a premature stop codon p.Leu88* in the zebrafish
orthologous gene, were previously described (21). Mutant em-
bryos have pronounced ventral body curvature, pronephric
cysts and pronephric duct dilatation which are all typical fea-
tures of PCD zebrafish models. Also characteristic for PCD, is the
randomisation of heart looping in mutants caused by static cilia
in the Kupffer’s vesicle. Homozygous mutants die at 8dpf with
severe oedema. To interpret the possible pathogenicity of the
c.571C>T (p.Leu191Phe) DNAAF1 mutation as causative for iso-
lated CHD phenotype in Family A, we performed genetic com-
plementation assays in the dnaaf1 mutant zebrafish line. mRNA
of mutant (c.571T) and wild-type (c.571C) human DNAAF1 was
injected into zebrafish clutches from dnaaf1þ/ intercrosses. In
mock-injected negative control clutches, about 16% of embryos
showed reversed heart looping and central heart phenotypes
(Fig. 2). This is fewer than the expected Mendelian ratio of 25%
for the homozygous mutant phenotype, because in dnaaf1-defi-
cient embryos the laterality of Kupffer’s vesicle is randomized
(21). Significant rescue of left-right axis defects (reversed or no
heart looping) was demonstrated at 72 h post fertilization in
dnaaf1þ/ inter-crossed embryos injected with human wild-type
DNAAF1 transcript. However, rescue was not significant for em-
bryos injected with the mutant mRNA, supporting the pathoge-
nicity of the c.571C>T mutation (Fig. 2). By comparison with
wild-type zebrafish lines kept in the same conditions, the
Figure 2. Genetic complementation of heart looping defects in dnaaf1/ mutant zebrafish embryos: Zebrafish embryos from dnaaf1þ/ heterozygote-heterozygote in-
ter-crosses were either mock injected (control, n¼405 embryos), or injected with mRNA expressed from human wild-type (wt, n¼425 embryos) and p.Leu191Phe-mu-
tant (mut, n¼ 547 embryos) pCS2þDNAAF1 constructs. In all cases, a mixture of normal looping (green), reversed looping (red) or ‘linear’ looping indicating a lack of
heart looping (orange) were seen and representative examples are shown at 72 h post fertilization (left panels). On the right, the bar graph quantifies the three positions
of heart looping in all three experiments, showing that phenotypic rescue is seen after injection of wild-type but not mutant RNA. n.s.¼not significant; *** P<0.001
(one-way ANOVA, n¼3 biological replicates). The dashed line indicates the 25% expected Mendelian ratio of embryos that should be homozygous mutant and manifest
a phenotype.
5Human Molecular Genetics, 2017, Vol. xx, No. xx |
Downloaded from https://academic.oup.com/hmg/advance-article-abstract/doi/10.1093/hmg/ddx422/4708237
by Library - Duncan of Jordanstone user
on 04 January 2018
background level of situs defects is<5% (Jeroen Bakkers, per-
sonal communication).
DNAAF1 interacts with IFT88, and the AAAþATPases
RUVBL1 and RUVBL2
To further model the pathogenic effect of the c.571C>T
(p.Leu191Phe) missense mutation and to understand the potential
functions of DNAAF1, we began by performing screens for inter-
actors of DNAAF1. A GAL4 yeast two-hybrid screen, using an oligo
dT-primed human retinal cDNA library, was performed to identify
further protein-protein interactions of wild-type DNAAF1. The
single positive clone identified by this screen encoded intraflagel-
lar transport protein IFT88. Confirmation was performed with a
dedicated “one-to-one” yeast two-hybrid assay (Fig. 3A), showing
that DNAAF1 interacted with both full length and N’-terminally
truncated IFT88, but not C’-terminally truncated IFT88. Co-
immunoprecipitation (coIP) assays confirmed that both endoge-
nous IFT88 (Fig. 3B) and exogenously-expressed IFT88 (Fig. 3C) in-
teracted with wild-type DNAAF1 (p.Leu191). Interactions of IFT88
with mutant DNAAF1 (p.Phe191) were either absent or diminished
(Fig. 3B and C) due to either reduced expression levels or reduced
stability of the mutant protein (Fig. 3B).
We then used streptavidin-II/FLAG tandem affinity purifica-
tion (SF-TAP) of N-terminal TAP-tagged wild-type and p.Phe191
mutant DNAAF1 to identify interacting proteins by mass spec-
trometry (Table 1, Supplementary Material, Table S2). In this
assay, the peptide counts corresponding to the interacting pro-
teins were highly reproducible between biological replicates
suggesting that interactions were stable. As expected, DNAAF1
was pulled down in all assays, confirming moderate levels of
protein expression, although levels were lower for the mutant
p.Phe191 protein again suggesting reduced expression levels or
stability. Consistent with the possible instability of the mutant
protein, several heat shock proteins (HSPA1A, HSPA5, HSPA8,
HSPA9, HSPA6 and HSP90AA1) were more strongly associated
with the mutant p.Phe191 DNAAF1 protein than the wild-type
protein (Table 1, Supplementary Material, Table S2). Both
RUVBL1 and RUVBL2 (also known as Pontin and Reptin, or RVB1
and RVB2), members of AAAþ (ATPases Associated with various
cellular Activities) protein family, associated with the wild-type
DNAAF1 protein, and the RUVBL1 interaction was reduced by
the DNAAF1 p.Phe191 mutation. CoIPs assays confirmed the in-
teraction of both endogenous RUVBL1 (Fig. 3D) and RUVBL2
(Supplementary Material, Fig. S1) with DNAAF1.
DNAAF1 localization to the ciliary basal body is
perturbed by loss of RUVBL1
In ciliated cells, DNAAF1 is dynamically localized throughout
the cell cycle. DNAAF1 is a cytoplasmic protein that is localized
to the basal body of the primary cilium and maintains centro-
some association throughout the cell cycle, with transient local-
ization to the mid-body and condensed chromosomes during
Figure 3. Interactions of DNAAF1 with IFT88 and RUVBL1: (A) Schematic diagram to show DNAAF1 and IFT88 domains. Full-length DNAAF1 contains 6 leucine-rich re-
peats (LRR), a coiled-coil domain (CC) and a proline-rich domain (PRO). IFT88 contains 3 N-terminal and 7 C-terminal tetratricopeptide repeats (TPR). A dedicated yeast
two-hybrid for DNAAF1-BD demonstrates interaction with full-length IFT88 and N-terminally truncated IFT88 (442–833). The interaction is not observed in C-terminal
truncated IFT88 (1–449). (B) Confirmation of the interaction between DNAAF1 and IFT88, demonstrated by co-immunoprecipitation assays comprising over-expression
of wild-type (wt; p.Leu191) or mutant (p.Phe191) FLAG-DNAAF1, pull-down of endogenous IFT88 by anti-IFT88 antibody and western blot (WB) with anti-FLAG. Input
whole cell extracts indicate significantly reduced levels of DNAAF1 mutant (p.Phe191) compared to wild-type protein, with b-actin used a loading control. Negative con-
trol IgG lanes and IgG heavy chain (HC) bands are indicated. (C) Co-immunoprecipitation assays of over-expressed wild-type (wt; p.Leu191) or mutant (p.Phe191) FLAG-
DNAAF1 and IFT88-eYFP, pull-down with anti-FLAG antibody and western blot (WB) with anti-GFP “Living Colors” antibody. Input whole cell extract and irrelevant con-
trol IgG lanes are indicated, with empty vector as the negative control. The largest IFT88 band that is immunoprecipitated by the wild-type DNAAF1 protein, is indi-
cated by the arrowheads, and this interaction is lost with the mutant DNAAF1 protein. Non-specific protein bands, indicated by the asterisks, are likely to be due to
cross-reaction of the secondary antibody with the anti-FLAG IgG used in these coIPs. (D) Interaction between DNAAF1 and RUVBL1 (Pontin) shown after over-expres-
sion of wildtype (p.Leu191) or mutant (p.Phe191) FLAG-DNAAF1, pull-down with anti-FLAG antibody and western blot (WB) blot with anti-RUVBL1 antibody.
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metaphase (23). In ciliated hTERT-RPE1 cells, endogenous
DNAAF1 localized distal to RPGRIP1L, but co-localized with
gamma-tubulin and centrin-3, confirming a specific basal body
localization that is adjacent to the transition zone
(Supplementary Material, Fig. S2A). Over-expressed FLAG-
tagged wild-type p.Leu191 and mutant p.Phe191 DNAAF1 had a
more diffuse cytoplasmic distribution, but also localized to the
ciliary base (Supplementary Material, Fig. S3A and B). Over-
expressed IFT88 partially co-localized with both wild-type and
mutant DNAAF1 at the ciliary base (Supplementary Material,
Fig. S3A and B), and in agreement with the biochemical interac-
tions between IFT88 and DNAAF1 (Fig. 3A–C). Endogenous
RUVBL1 had a predominantly nuclear localization and did not
appear to extensively co-localize with DNAAF1 (Supplementary
Material, Fig. S2B).
Since the RUVBL1/RUVBL2 complex has been implicated in
the assembly of both protein and ribonucleoprotein complexes
(26), we reasoned that RUVBL1 and RUVBL2 could mediate the
pre-assembly of a putative DNAAF1 protein complex that might
include IFT88 as a component. To test this, we depleted the lev-
els of either RUVBL1 or RUVBL2 by siRNA knock-down in
hTERT-RPE1 cells. Knock-down was assessed by real-time PCR
(Supplementary Material, Fig. S4A) and western blotting
(Supplementary Material, Fig. S4B), showing more extensive
loss of RUVBL1 at the transcript and protein levels than for
RUVBL2. We therefore focused on RUVBL1 knock-downs in
hTERT-RPE1 cells, and quantified the degree of co-localization
between endogenous IFT88 and DNAAF1, and IFT88 with c-
tubulin (Fig. 4A). RUVBL1 knockdown significantly increased the
co-localization of endogenous IFT88 with either wild-type
DNAAF1 (p.Leu191) or mutant DNAAF1 (p.Phe191) (Fig. 4B), but
had no effect on the co-localization of IFT88 with c-tubulin
(Fig. 4C). This suggests that reduced levels of RUVBL1 perturb
the localization or transport of DNAAF1, without affecting over-
all ciliary ITF. Both wild-type and mutant DNAAF1 had similar
levels of co-localization with ciliary IFT88 (Fig. 4B), suggesting
that they have a similar functional association with RUVBL1.
Asymmetric distribution of RUVBL1 at the zebrafish
Kupffer’s vesicle and mouse embryonic node is
dependent on DNAAF1
Since RUVBL1 could mediate an apparent functional association
between DNAAF1 and IFT88, we next asked if RUVBL1 could me-
diate normal laterality phenotypes through DNAAF1. We first as-
sessed the localization of Ruvbl1 transcripts in the mouse
embryonic node using whole-mount in situ hybridization (WISH).
In head-fold stage embryos, Ruvbl1 was ubiquitously expressed,
but in the embryonic node a low but discernible asymmetric left-
sided distribution was evident (Fig. 5A). We next assessed the lo-
calization of RUVBL1 protein in wild-type mouse embryos using
light-sheet immunofluorescence microscopy. In late head fold
and early somite stage embryos (E7.25-E7.5), high levels of
RUVBL1 expression exhibited a left-sided distribution in the node,
with only moderate expression in the surrounding tissues
Table 1. Proteins identified by SF-TAP pull-downs with DNAAF1 p.Leu191 wild-type or p.Phe191 mutant proteins: Unique peptides (>5 for each
protein) were identified by mass spectrometry, in at least two out of three biological replicates. Results are ordered from the highest to lowest
number of pulled-down peptides. Statistically significant differences in peptide numbers for wild-type compared to mutant pull-downs are in-
dicated (Chi-squared test; n.s. not significant, *P¼ 0.05, ****P¼ 0.0001; for n¼ 3 biological replicates). Log-fold changes of mutant to wildtype pro-
tein levels are also shown, where a negative value indicates an increased association with wildtype protein and a positive value indicates an
increased association with the mutant protein. A “þ” indicates exclusive binding of that protein species to the p.Phe191 mutant protein.
Several proteins of the chaperonin containing TCP1 (CCT) complex also associated with the mutant protein only, but have been removed for
brevity. Further details are available in Supplementary Material, Table S2
Protein
symbol
Protein
function
UniProt
accession
number
Protein
size (kDa)
No. unique
peptides associated
with wild-type
protein
Log-fold
change (mutant vs
wild-type protein)
Chi-squared
test (mutant
vs wild-type
protein)
DNAAF1 Dynein assembly factor Q8NEP3 80 378 0.058 *
HSPA9 Heat-shock protein P38646 74 121 0.004 n.s.
HSPA8 Heat-shock protein P11142 71 89 þ0.181 ****
HSPA1A Heat-shock protein P08107 70 86 þ0.186 ****
HSPA5 Heat-shock protein P11021 72 53 þ0.075 n.s.
ACACA Acetyl co-a carboxylase Q13085 266 50 0.344 n.s.
RUVBL1 Pontin Q9Y265 50 28 0.049 n.s.
TUBB4B Tubulin P68371 50 24 þ0.602 ****
TUBA1B Tubulin P68363 50 20 þ0.531 ****
RUVBL2 Reptin Q9Y230 51 19 þ0.083 ****
ACTB Beta actin P60709 42 15 0.030 n.s.
UBA52 Ubiquitin-ribosomal protein fusion product P62987 15 10 þ0.146 n.s.
PC Pyruvate carboxylase P11498 130 8 þ0.026 n.s.
TUBB Tubulin P07437 50 8 þ0.495 ****
SLC25A5 Solute carrier P05141 33 5 þ0.643 ****
EEF1A1 Eukaryotic translation elongation factor P68104 50 4 þ0.176 n.s.
CCT6A chaperonin containing T complex polypeptide P40227 58 3 þ0.493 n.s.
ATP5A1 ATP synthase P25705 60 3 þ0.523 n.s.
HSPA6 Heat-shock protein P17066 71 0 þ n/a
HSP90AA1 Heat-shock protein P07900 85 0 þ n/a
SUGT1 Suppressor of G2 allele of SKP1 Q9Y2Z0 41 0 þ n/a
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(Fig. 5B). At later stages of embryogenesis (6–8 somite pairs, E9.0),
asymmetric RUVBL1 expression was not apparent and the highest
levels of expression were in the developing mouse heart. RUVBL1
was widespread throughout the atrial chambers and primitive
ventricle, and in the developing vasculature (Fig. 5B).
To substantiate an in vivo functional association between
DNAAF1 and RUVBL1, we used ISH to visualize ruvbl1 expres-
sion in wild-type and dnaaf1/ mutant zebrafish embryos at
the 5 to 9 somite stages. Preliminary experiments indicated that
ruvbl2 was ubiquitously expressed (data not shown). However,
rubvl1 expression was asymmetric in wild-type zebrafish em-
bryos, with significantly higher expression on the left side of the
Kupffer’s vesicle (Fig. 6A–C), consistent with the asymmetric
distribution in the mouse embryonic node. In dnaaf1/ em-
bryos, this asymmetrical distribution was abolished, and em-
bryos showed a central expression of ruvbl1.
Discussion
The link between PCD and CHD has long been recognized. Situs
inversus occurs in around 50% of patients with PCD, usually with
a total mirror-image arrangement of the abdominal organs in-
cluding the heart, an arrangement that is not usually pathologi-
cal. However, CHD is more common in PCD than in the general
population and one study demonstrated heterotaxy in 6.3%
of>300 PCD patients, including 8 patients with complex cardio-
vascular lesions (14). Mouse models of PCD show even higher
rates of complex CHD (27,28), suggesting that in humans in utero
loss of embryos with severe CHD could account for this differ-
ence. This appears to hold true in inversus viscerum (Dnah11iv)
mutant mice, reported as a model of PCD (29), where a 40% inci-
dence of CHD is seen prenatally but only 5% is seen in viable
term animals (30). Nakhleh et al. (2012) demonstrated that the
converse was also true, since in a cohort of patients with heter-
otaxy, 42% were found to have ciliary dysfunction, similar to
that seen in PCD (16). These patients had low NO levels, or levels
bordering the cut-off values indicative for PCD. Genomic se-
quencing in these patients demonstrated an increased burden
of non-coding variants in PCD genes, but none was found to
have biallelic pathogenic mutations in a PCD gene. There was a
high level of single heterozygous PCD gene mutations, as well
as mutations in two different PCD genes in the same patient. It
was suggested that the additive effects of this mutational load
may therefore play a role in the aetiology of heterotaxy in these
patients (16). A recent unbiased forward genetic screen across
the mouse genome for recessive mutations causing congenital
heart defects, revealed a high mutational burden in cilia-related
genes, including mutations in PCD genes and other cilia motility
factors (28).
In this study, we describe four families with mutations in
the known PCD gene, DNAAF1. Three have affected children
with a typical PCD phenotype arising from mutations in
DNAAF1 predicted to truncate the protein, causing a total loss of
DNAAF1 protein. As a phenotypic series, there are insufficient
A B
C
Figure 4. Disruption of co-localization of wild-type DNAAF1 with IFT88 after RUVBL1 knockdown: (A) Immunofluorescence confocal microscopy of ciliated hTERT-RPE1
cells showing co-localization of over-expressed DNAAF1 p.L191 wild-type (wt) or p.F191 mutant proteins (red) with endogenous IFT88 (green) at cilia, and basal bodies
marked by c-tubulin (blue). Examples of co-localization, indicated by arrowheads, are shown in the magnified insets. Scale bars¼10 lm. (B) Knockdown of RUVBL1 dis-
rupts the co-localization (expressed as Pearson’s R value) between IFT88 and either wild-type or mutant DNAAF1. Statistical significance of pair-wise comparison with
scrambled (Scr) negative control siRNA (#) indicated by: n.s. not significant; ** P<0.01; *** P<0.001 (paired Student t-test; error bars indicate s.e.m. for n¼3 biological
replicates). (C) Co-localization of IFT88 with c-tubulin as for (B), showing no significant effect of RUVBL1 knockdown.
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numbers to calculate statistical significance but there appears
to be a high incidence of CHD in these families, with 5 of 8 pa-
tients having complex CHD. Cardiac defects have not been
noted in the seven previously reported PCD families with
DNAAF1 mutations (17,18), but our families appear to have a
higher rate than would be expected in an unselected PCD co-
hort, for which the incidence of CHD is currently estimated at
3.5–6% of cases (14). Moreover, we also describe a family with a
novel DNAAF1 missense variant, p.Leu191Phe, that only mani-
fests a cardiac phenotype. This variant fulfils the major criteria
for a pathogenic mutation, and its pathogenicity was confirmed
by the absence of genetic complementation in dnaaf1/ mutant
zebrafish embryos (Fig. 2). Both affected siblings in Family
A (Fig. 1A) had complex phenotypes of isolated CHD without
any clinical manifestations of typical PCD: neither of the two af-
fected siblings have suffered the respiratory symptoms that
usually indicate PCD. Ciliary beat frequency and EM were nor-
mal and refuted a clinical diagnosis of PCD in this family. These
observations suggest that CHD and PCD form a phenotypic con-
tinuum rather than comprising distinct clinical entities.
The majority of biallelic DNAAF1 mutations previously associ-
ated with PCD were reported to be loss-of-function alleles
(17,18), and we suggest that the homozygous p.Leu191Phe mu-
tation may be hypomorphic since it causes isolated CHD.
However, further work is required to understand whether this
missense mutation has significantly different cellular effects
compared to loss-of-function alleles causing CHD and PCD. Our
in vitro data (Fig. 3B) indicates that the p.Phe191 mutation
causes reduced DNAAF1 protein levels, presumably due to in-
stability or increased degradation of the mutant protein. We ex-
pect that further genetic screening will identify additional
patients with isolated complex CHD that carry mutations in
PCD genes, even if respiratory ciliary function is apparently nor-
mal. Identification of these genetic aetiologies may thereby re-
fine prognosis, disease stratification and categorization during
the medical and surgical management of these patients (31).
This is of potential clinical importance because complex CHD
carries a high burden of post-surgical morbidity and mortality
(31). It is also important to note that DNAAF1 genotype-
phenotype correlations are likely to be unusually broad because
heterozygous germline mutations in DNAAF1 (for example,
p.Gln307Glu) are associated with an increased risk of testicular
germ cell tumours in humans (23,32,33), and rare heterozygous
missense mutations are also associated with neural tube de-
fects (33).
Our observation of a phenotypic continuum between CHD
and PCD raises questions about the pathomechanism of the
p.Leu191Phe missense mutation. This mutation appears to af-
fect nodal ciliary function, manifesting as heterotaxy and CHD,
whereas respiratory ciliary function is normal. Two possibilities
Figure 5. Left-sided asymmetric expression of RUVBL1 at the mouse embryonic node: (A) whole-mount in situ hybridization (WISH) of Ruvbl1 probes for whole-mount
head-fold stage wild-type C3H/HeH mouse embryos showing widespread, ubiquitous Ruvbl1 expression and left-sided asymmetric distribution at the embryonic node.
Grey frame indicates magnified inset (lower left) with a second example at lower right, with Ruvbl1 expression indicated by arrowheads. Scale bar¼100 lm. (B) Light-
sheet microscopy images of whole-mount immunofluorescence for RUVBL1 (red) and DAPI (blue) in the wild-type C57BL/6 mouse E7.25 and E7.5 (late head fold and 2–4
somite stage) embryonic node, and E9.0 (6–8 somite stage) vasculature and heart loop. Left (L) and right (R) sides are indicated. RUVBL1 is asymmetrically distributed at
the murine embryonic node (upper two panels). RUVBL1 is present in a widespread distribution throughout the atrial chambers, primitive ventricle and developing
vasculature (lower two panels). Scale bars¼100 or 200 lm, as indicated. Abbreviations: rAC and IAC, right and left atrial chambers; EN, embryonic node; L, left; N, noto-
chord; PV, primitive ventricle; R, right; ST, septum transversum.
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could explain this observation. Firstly, it may be that subtle de-
fects in motile ciliary function are present but were not identi-
fied by standard clinical investigations. These subtle defects
may be sub-clinical in their effect on respiratory cilia and muco-
ciliary clearance, but could still disrupt nodal ciliary function
because of the exquisitely sensitive nature of coordinated ciliary
beat at the node during embryonic development. Secondly, the
missense mutation could affect DNAAF1 functions that are dis-
tinct from its known role in the assembly of dynein arms.
To test the latter possibility, we sought to identify proteins that
interact with DNAAF1 in order to infer new putative functions.
Yeast two-hybrid and co-immunoprecipitation experiments
identified and confirmed that DNAAF1 interacts with the intra-
flagellar transport protein IFT88 (Fig. 3A–C). As a component of
the IFT-B complex, IFT88 is essential for the trafficking of pro-
tein cargoes along axonemal microtubules (34). This suggests
that DNAAF1 could mediate the delivery of dynein arm compo-
nents directly to the intraflagellar transport complexes. This is
supported by immunofluorescence studies that demonstrate
the co-localization between DNAAF1 and ciliary IFT88 (Fig. 4A
and B, Supplementary Material, Fig. S3A and B). TAP and co-
immunoprecipitation experiments also confirmed interactions
of DNAAF1 with both RUVBL1 (Table 1, Fig. 3D) and RUVBL2
(Table 1, Supplementary Material, Fig. S1).
RUVBL1 and RUVBL2 are DNA-dependent AAAþATPases in-
volved in numerous cellular processes, and are essential
components of protein complexes that mediate chromatin
remodelling, transcription factor function, and snoRNP assem-
bly and maturation (35). RUVBL1/RUVBL2 form hetero-hexamer
and dodecameric ring-like structures that are the core of many
complexes, including the RT2P complex, which is important in
the biogenesis of snoRNPs and telomerase. RUVBL1 and RUVBL2
form this complex with Pih1 (Protein interacting with Hsp90)
and Tah1 (TPR-containing protein associated with Hsp90), two
Hsp90 interactors (36). Interestingly, our TAP experiments dem-
onstrated that HSP90 and SUGT1 both interact with DNAAF1.
SUGT1 is a TPR repeat-containing protein and a known co-
chaperone of HSP90 that interacts with many LRR domain-
containing proteins (37). That DNAAF1 binds RUVBL1/RUVBL2
might indicate a putative model of interaction where an RT2P-
like complex is formed from RUVBL1/RUVBL2, a TPR-repeat con-
taining protein (for example SUGT1) and a PIH1-domain
containing protein. In this model, appropriate PIH1 domain-
containing proteins could include DNAAF2/KTU and MOT48,
both linked to cytoplasmic pre-assembly of dyneins (38–40).
Furthermore, DNAAF1 appears to associate with IFT-B complex
(represented by IFT88) at the ciliary base, suggesting that it is
connected directly to IFT of the ODA into cilia and providing an
explanation for the previous observation of small amounts of
DNAAF1 in ciliary axonemes (18). We hypothesise that DNAAF1
mediates both dynein arm assembly through an RT2P-like com-
plex, and is then further required to couple this process to the
Figure 6. DNAAF1-dependent left-sided asymmetric expression of RUVBL1 at the zebrafish Kupffer’s vesicle: (A) in situ hybridization (ISH) of Ruvbl1 expression at
Kupffer’s vesicle (thin dashed black line) in wild-type heterozygous dnaaf1þ/ and mutant homozygous dnaaf1/ zebrafish embryos, at the 5 to 9 somite stages, visual-
ized from dorsal views as indicated in the top left inset. Localized expression is indicated by arrowheads, and the mid-line of the notochord is shown by the thick
dashed black line. Left (L) and right (R) sides are indicated. (B) Bar graph shows a significantly higher proportion of wild-type zebrafish (þ/) have left-sided localisation
of ruvbl1 when compared to diffused central localization in mutant (/) embryos (P¼0.0023, unpaired Student’s t-test). (C) Additional examples of ruvbl1 expression
at Kupffer’s vesicle in unaffected dnaaf1þ/ heterozygous and dnaaf1/ affected mutant zebrafish embryos.
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IFT-B machinery (Fig. 7). In support of this hypothesis, we ob-
served that loss of RUVBL1 perturbed the co-localization of
DNAAF1 with IFT88 in the cilium (Fig. 4B).
Both RUVBL1 and RUVBL2 have previously been implicated
in cardiac development in zebrafish (41), but our model implies
that RUVBL1/RUVBL2, in addition to other roles, also have a
more specific ciliary assembly function. In support of this
model, RUVBL1/RUVBL2 interact with other ciliary leucine-rich
repeat proteins in addition to DNAAF1 (which is also known as
LRRC50). LRRC6/Seahorse is another dynein arm assembly fac-
tor (42), and a recent study identified an interaction between
RUVBL2/Reptin and LRRC6/Seahorse (43). Consistent with our
model, zebrafish embryos with a loss-of-function ruvbl2 muta-
tion had a typical ciliopathy phenotype (43), including ventral
body curvature and kidney cysts, that are features also observed
in ruvbl1 mutants (44). Zebrafish ruvbl2 mutants had an absence
of dynein arms in motile cilia, suggesting that RUVBL2 mediates
dynein arm stability and assembly or maintenance (43).
However, RUVBL1 evidently has other direct or indirect roles in
these processes because we unexpectedly observed asymmetric
left-handed distribution of RUVBL1 both at the embryonic
node in mice and the Kupffer’s vesicle in zebrafish embryos
(Figs 5A and B, 6A). The asymmetric distribution was dependent
on DNAAF1 (Fig. 6A–C), indicating that the DNAAF1-RUVBL1 as-
sociation has a possible functional role in symmetry breaking.
To explain these observations, one possibility is that dynein
arm assembly in nodal cilia is initially specified on the left of the
node, at least during the early formation of the embryonic node. In
this model, the earlier assembly or maturation of nodal cilia on the
left would contribute to establishing leftward nodal fluid flow. As a
consequence, earlier dynein arm assembly on the left of the node
could then ensure that immotile cilia on the perinodal crown cells
in this region respond to nodal flow before those on the right of the
node. Furthermore, the modulation of cilia motility between the
two sides of the node could also act to amplify any early asymme-
try imposed by the initial weak levels of leftward nodal flow (45).
This hypothesis is supported by the existence of interlinked feed-
back loops for regulating the expression of Cerl2 and Wnt3, two
key mediators of the flow signalling cascade, that could amplify a
small initial signal (46). These possibilities do not exclude a direct
gene regulatory role for RUVBL1: it could, for example, also act as a
transcriptional activator of asymmetrically expressed genes such
as Nodal, which is preferentially expressed on the left side of the
node. Our intriguing observation of asymmetric distribution of
RUVBL1 at the node requires further investigation in animal mod-
els in order to understand the unexpected role of RUVBL1 (and pos-
sibly RUVBL2) in left-right axis determination.
In summary, we have shown that biallelic mutations in a
known PCD gene, DNAAF1, are associated with isolated CHD, in
the absence of any clinical evidence for PCD. This finding con-
firms a shared aetiology between PCD and CHD that has been
suggested but not proven in previous studies. This phenotypic
continuum provides new insights into the pathogenesis of iso-
lated CHD, suggesting the existence of a putative dynein arm
assembly complex that contains DNAAF1, IFT88 and RUVBL1. It
also highlights a possible functional association between
DNAAF1 and RUVBL1 during the establishment of embryonic
laterality that merits further investigation.
Materials and Methods
GenBank accession numbers
DNAAF1: RefSeq NM_178452.5 and NP_848547.4
Patients and families
Families with individuals affected with Congenital Heart Disease
were recruited and underwent detailed clinical assessment.
Additional families with mutations in DNAAF1 were ascertained
through the national PCD diagnostic service, either at University
College London or the Leeds Genetics Laboratory. These families
had a clinical diagnosis of PCD confirmed by standard clinical di-
agnostic testing and symptoms of chronic respiratory disease.
Ethical approval for molecular genetics research studies was
given by Yorkshire Research Ethics Committee (reference no. 11/
H1310/1). Full, written, informed consent was provided by all par-
ticipating individuals and families. Genomic DNA was extracted
from peripheral blood leukocytes by standard salt extraction.
Clinical testing for PCD
Nasal nitric oxide (nNO) levels were measured by a chemilumi-
nescence analyser and are reported in nl/min. Two NO mea-
surements were taken per nostril during breath holding, with
the mean of these being taken as the nNO level. Ambient NO
Figure 7. Proposed model of DNAAF1 function in an RT2P-like complex and the
IFT-B ciliary transport complex: Unfolded dynein arm components (brown) are
folded via the action of DNAAF1 within an ODA pre-assembly module consisting
of the AAAþATPases RUVBL1 and RUVBL2 (tan), RT2P-like complex proteins
(grey) such as DNAAF1, DNAAF2/KTU, and other chaperone proteins (blue) such
as SUGT1 and HSP90. In addition to dynein arm assembly through an RT2P-like
complex, DNAAF1 also associates with the IFT-B complex (pink; represented by
IFT88) allowing dynein arm assembly to be coupled to ciliary transport. RUVBL1
may also have a separate, direct gene regulatory role on asymmetrically ex-
pressed genes such as Nodal.
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level was recorded before each test. Respiratory epithelial cells
were then obtained by nasal brush biopsy and suspended in
Medium 199. High speed video and transmission electron mi-
croscopy were used to analyse ciliary motility and structure, as
previously reported (47). At least 100 cilia cross-sections ana-
lysed in TEM where available.
Homozygosity mapping
Affymetrix 6.0 SNP microarray analysis v.6.0 (Affymetrix) was
performed for both affected individuals in Family A. Data analy-
sis was carried out using SnpViewer v0.9.2 (https://sourceforge.
net/projects/snpviewer/) to identify shared regions of homozy-
gosity. This created a visual output plus numerical chromosome
coordinates of regions of interest.
Whole exome sequencing
WES was performed by three separate centres (see
Supplementary Material). In Family A, WES was undertaken
with Agilent SureSelect V5 Human All Exon libraries (Agilent
Technologies, Santa Clara, CA, USA) and 100 bp paired-end se-
quencing was performed on the Illumina HiSeq2000 platform
(Illumina, San Diego, USA) or the Illumina Miseq. FASTQ files
were aligned to GRCh37 by Novoalign (Novocraft Technologies).
.sam and .bam files were processed using SAMtools (48), Picard
(Broad Institute) and the Genome Analysis Toolkit (GATK, Broad
Institute, Cambridge, MA) (49). GATK’s Haplotype Caller was
used to call variants. Recalibration was performed as per
GATK’s guidelines (50). Ensembl’s variant effect predictor was
used to determine the functional consequences of variants (51).
In-house generated perl scripts (see Web Resources; date last
accessed October 2017) were used to remove variants with a
Minor Allele Frequency (MAF) of 1% or higher present in dbSNP
138 and previous, NHLBI Exome Sequencing Project (ESP) Exome
Variant Server, the Exome Aggregation Consortium (ExAC) and
gnomAD databases, and over 3000 ethnically-matched locally-
sourced control samples. A similar pipeline was followed for
variant calling in Family B (24), C & D (25). Variants were re-
tained that were predicted to have a functional effect on the
protein, including missense, splice site variants and indels.
Variants were then retained which followed the predicted in-
heritance pattern in the family. Variants were retained if pre-
dicted “pathogenic” by any one of Polyphen2 (52), SIFT (53) or
Condel (54). Finally variants were ranked by CADD score (55)
and those with CADD score>15 were retained. Sanger sequenc-
ing was performed using standard methodologies. Primer pair
sequences are available on request.
Whole genome sequencing and breakpoint analysis
Approximately 1 mg of genomic DNA was sheared using a
CovarisS2 (Covaris, Inc., Woburn, MA, USA). The fragmented DNA
was used to create an Illumina compatible whole genome se-
quencing (WGS) library with NEBNext Ultra reagents, following
manufacturer’s protocols throughout (New England Biolabs,
Ipswich, MA, USA). The library insert size selection was 300–
400bp and the final enrichment PCR consisted of 6 rounds of PCR.
Library quality was checked using an Agilent Bioanalyser (Agilent
Technologies, Santa Clara, CA, USA) before sequencing was per-
formed on a single lane of an Illumina HiSeq3000 (Illumina, San
Diego, CA, USA), which generated paired-end 151bp reads. Raw
sequence data were converted to FASTQ.gz format using
bcl2fastq v.2.16.0.10, and the quality of these data was assessed
using FastQC v.0.11.5 (see Web Resources; date last accessed
October 2017). Adaptor sequences and low-quality bases (Q
score10) were trimmed from sequence reads using Cutadapt
v.1.9.1 (see Web Resources) before being aligned to an indexed
human reference genome (hg19) using BWA MEM v.0.7.13 (56).
Reads were sorted by chromosome coordinate and PCR dupli-
cates were marked using Picard v.2.1.1 (see Web Resources; date
last accessed October 2017). Aligned sequence reads were visual-
ized using the Integrative Genome Viewer v.2.3.80 (57).
Alignments mapping to the DNAAF1 locus were extracted for in-
terrogation using samtools v.0.1.18 (48) to identify putative break-
point spanning reads. BLAT was used to determine the genomic
coordinates of both the 5’ and 3’ sequences (58).
A PCR amplicon was optimized to amplify across the identi-
fied breakpoint using primers 5’-dTGTAAAACGACGGCCAGTTG
TTCTGGAGGGACGATGAG-3’ (common forward) and dCAGGA
AACAGCTATGACCTTGTTGTGGCAGCTGTGAAA (deletion re-
verse), which generated a 377-bp PCR product. A second reverse
primer 5’-dCAGGAAACAGCTATGACCAGCCATCAAGCCTATTTC
CAA-3’ (reverse normal) was designed to work in combination
with the common forward primer to amplify a larger 551-bp
PCR product specific to the normal allele. All primers contained
universal tags (underlined) to enable Sanger sequencing using
our diagnostic laboratory workflow. Each PCR consisted of 0.5 ml
DNA (1 mg/ml), 11ml MegaMix (Microzone Ltd., Haywards Heath,
UK), 1 ml of 10 mM common forward primer and 1 ml of 10 mM re-
verse deletion or reverse normal primer. For each PCR thermo-
cycling conditions comprised a pre-heat step at 94 C for 5 min
followed by 30 cycles of 94 C for 30 s, 55 C for 1 min, and 72 C
for 45 s. A final extension step was carried out at 72 C for 5 min.
CNV analysis
The ExomeDepth package (see Web Resources) was used to as-
sess CNVs in exome data from Family A. This program compares
read depth between the test sample and 5–10 control samples.
This was annotated to indicate common CNVs from control popu-
lations (59). CNV calls were then ranked by the Bayes Factor (the
log10 likelihood ratio of data for the CNV call divided by the nor-
mal copy number). CNV calls were manually inspected to assess
read ratio and the genes affected by dosage changes. The genes
were cross-referenced with current literature, cilia-related gene
databases and exome call data for each sample.
Gateway cloning
The c.571C>T mutation was inserted into a DNAAF1 Gateway
entry clone to form a mutant construct by site-directed muta-
genesis (SDM) using the Q5 site-directed mutagenesis kit and
protocol (New England Biolabs). A SNP of unknown function,
c.1634T>G, was removed by SDM. Following this, Gateway LR
Clonase reaction (Thermo Fisher Scientific) was performed to
subclone mutant and wild-type cDNA into entry vectors
pCS2þand GW331 for SF-TAP. Bacterial transformation and
mini/maxi preps (Qiagen) were performed for construct growth
and DNA extraction. All cDNA clone sequences were confirmed
by Sanger sequencing. Primer sequences available on request.
Zebrafish mRNA transcription and microinjection
Microinjection and analysis of dnaaf1/ zebrafish was per-
formed as previously described (21). pCS2þ constructs were
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linearized by digestion with NotI. mRNA was created by SP6
mMessage mMachine kit (Ambion). Microinjection was per-
formed according to previously published methods (21,60) into
the yolks of 1–4 cell stage embryos. For in situ hybridization,
zebrafish embryos were fixed at the 5–9 somite stage.
Zebrafish whole mount in situ hybridisation
ruvbl1 probe DNA template was amplified from zebrafish cDNA
using forward GAAGGAGAGAGTGGAGGTCG and reverse
CTCTTCGCTGATGTTGAGGC primers and cloned into pGEMT
vector (Promega) according to standard protocol. Antisense RNA
probe was generated using T7 RNA polymerase and purified by
ammonium acetate precipitation. Zebrafish embryos were col-
lected from dnaaf1þ/ heterozygote- heterozygote intercross
matings and developed until the 5-somite stage, after which
they were fixed overnight with 4% PFA at 4 C. Embryos were
washed with PBST (PBS plus 0, 1% Tween20) and gradually (in
steps of 25%) brought to 100% methanol and stored at 20 C (at
least 24 h). Upon start of the in situ hybridization protocol, em-
bryos were rehydrated to 100% PBST (in steps of 25%) and
treated with proteinase K (10 mg/ml; Promega) for 1 min and
re-fixed in 4% PFA for 20 min. Embryos were washed in PBST
(3 times, 5 min) and prehybridized in Hybþ (de-ionized formam-
ide 55–60x, SSC 5x, Heparin 50 mg/ml, tRNA 500 mg/ml, Tween20
0, 1%, Citric Acid to pH6) at 68 C for at least 2 h.
Prehybridization mix was replaced with preheated Hybþmix
containing 200–300ng of RNA probe and incubated over night
at 68 C. The next day, embryos were washed with Hyb-
(Hybþminus Heparin and tRNA) to 100 2X SSC (in steps of 25%)
for 15 min at 68 C and subsequently with 0.2X SSC to 100%
PBST (in steps of 25%). Next, embryos were treated with block-
ing solution (10% blocking buffer, Roche) for at least 2 h and sub-
sequently incubated with anti-DIG antiserum (1: 2000 anti-DIG
Fab, Roche) at 4 C overnight. Unbound antibodies were washed
away with six PBST washes (each 15 min). Finally, PBST was
replaced with staining solution (0.1M TrisHCl pH9.5, 0.05M
MgCl2, 0.1M NaCl, 0.1% Tween20). Staining was performed with
NBT/BCIP (stock solution, Sigma) and embryos were monitored
every 15–30 min. When staining was optimal, embryos were
washed with PBST and brought to 100% methanol (in steps of
20%) and stored at 20 C for at least 24 h. Embryos were im-
aged in 100% glycerol using IX53 inverted microscope
(Olympus). Genotyping was performed as described below.
Zebrafish DNA isolation and genotyping
For isolation of DNA, early stage zebrafish embryos were
dechorionated and lysed in 100 ml DNA extraction buffer (10 mM
Tris pH8, 2 mM EDTA, 0, 2% Triton X-100, 200 mg/ml proteinase
K) for 60 min at 65 C. Proteinase K was inactivated by boiling at
95 C for 15 min. 1 ml of DNA template was used in PCR reaction
for dnaaf1 genotyping with forward CCTGTATCCTCTTCAG
AATTACCAA and reverse GGGCCAAAGTTTGACAATGA primers.
Amplified PCR products were sequenced using EZ-Seq
(Macrogen) and analysed using GeneStudio software.
Tandem affinity purification
HEK293 cells at 70% confluence were transfected with mutant
(p.Phe191) or wild-type (p.Leu191) DNAAF1 SF-TAP constructs us-
ing Lipofectamine 2000 (Thermo Fisher Scientific), following the
manufacturer’s guidelines. After 4 h media was changed for
DMEM-F12þ 10% foetal calf serum (FCS). At 48 h, cells were col-
lected in 1PBS and lysed in lysis buffer (50 mM Tris-Cl pH8.0,
150 mM NaCl, 1%[v/v] NP40, 0.5 mM EDTA) supplemented with
protease inhibitors (Thermo Fisher). Lysates were centrifuged at
200  g for 5min at 4 C. Approximately 2 mg of lysate was
incubated with 100 ml of washed streptactin “Superflow” beads for
1.5 h at 4 C with end-to-end mixing. The beads were pelleted at
5000  g and the supernatant discarded. Streptactin beads were
transferred to a microspin column and excess fluid was removed
by gravity. 500 ml ice-cold wash buffer (1xTBS, 1xprotease-phos-
phatase inhibitors, 0.1%[v/v] NP40) was added, and the column
spun down for 10s at 1000  g. This wash was repeated a further
two times. Bound proteins were eluted with 200 ml ice-cold D-des-
thiobiotin elution buffer with a 15 min incubation on ice: 100 mM
Tris HCl pH8, 150 mM NaCl, 1 mM EDTA, 2.5 mM to 10 mM D-des-
thiobiotin. This reaction was transferred to new microspin col-
umns and centrifuged at 1000  g for 10 s to elute proteins. The
eluate was incubated with 50 ml of washed Anti-FLAG M2 affinity
gel beads (Sigma Aldrich) for 1.5 h with end-over-end mixing. The
beads were pelleted at 1000  g, washed with 500 ml of ice-cold
wash buffer three times, and washed once with 500 ml ice-cold
1xTBS/PBS. Bound proteins were eluted with 200 ml of ice-cold
FLAG peptide elution buffer [200 mg/ml FLAG peptide (Sigma
Aldrich) in 1xTBS/PBS] for 15 min on ice. Beads were pelleted at
1000  g and the eluate transferred to a fresh tube. Precipitated
proteins were sent for mass spectrometry.
Yeast two-hybrid interactions
A GAL4-based yeast two-hybrid system (HybriZAP, Stratagene,
USE) was used to identify proteins that interact with DNAAF1.
The DNA-binding domain fused to the human DNAAF1 (pBD-
DNAAF1) was used as bait for screening a human oligo-d(T)
primed retina cDNA library containing 1.9 106 primary clones
fused to the activation domain (pAD). Clones were plated on
amino acid dropout plates lacking Trp, Leu and His, containing
1 mM 3-aminotriazol, and selected for growth. Clones were then
patched on medium additionally lacking adenine and selected
for growth and a-galactosidase activity by the activation of the
MEL1 reporter gene. The latter was done using 20 mg/ml of the
chromogenic substrate 5-bromo-4-chloro-3-indolyl a-D-galacto-
pyranoside (X-a-Gal) in the dropout plates and selecting the
positive clones that developed a blue-green colour. Further se-
lection of positive clones was based on b-galactosidase activity
by the activation of the LacZ reporter gene, which was detected
by a filter-lift assay.
Co-immunoprecipitation
HEK293 cells were transfected with SF-TAP-DNAAF1 mutant
(p.Phe191) or wild-type, and co-transfected with or without an
eYFP-IFT88 construct, using Lipofectamine 2000 (Thermo Fisher
Scientific) according to the manufacturer’s protocols. After 4 h the
media was changed to DMEM-F12þ 10% FCS. At 48hr, cells were
collected in 1PBS and lysed in lysis buffer [50 mM Tris-Cl pH 8.0,
150 mM NaCl, 1%[v/v] IGEPAL-630 (Sigma-Aldrich), 0.5 mM EDTA]
supplemented with protease inhibitors (Thermo Fisher).
The lysate was centrifuged at 14, 000  g for 15 min. Protein
concentration was determined using a Bradford assay. 1500 mg
of protein was pre-cleared with 30 ml of washed protein
A-Sepharose beads (Roche) for 30min at 4 C. Beads were re-
moved by centrifugation at 1000 x g at 4 C for 1min. 1 mg of the
appropriate antibody was incubated with the supernatant for
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2 h at 4 C on an orbital shaker. The incubation buffer consisted
of 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.5 mM EDTA, 1x prote-
ase inhibitors (Thermo Fisher Scientific). Immunocomplexes
were captured by the addition of 70 ml protein A-Sepharose
beads and incubating overnight at 4 C. The beads were col-
lected by centrifugation at 1000xg and washed three times with
500ul ice-cold wash buffer (150 mM NaCl, 50 mM Tris-HCl pH
8.0, 0.5 mM EDTA, 0.1%[v/v] NP40, 1x protease inhibitors). 20 ml
2%[w/v] SDS was used to elute proteins and left for 30min at
room temperature. The sample was then centrifuged at 14, 000
x g for 2min and the supernatant collected. Lysates were elec-
trophoresed in NuPAGE 4–12% Bis-Tris gels and transferred to
PVDF membranes. Membranes were blocked in 5%[w/v] non-fat
skimmed milk (“Marvel”) in PBST for 2 h. Membranes were
washed four times in PBST (10 min incubations) and incubation
in primary antibody was performed for 30min (anti-FLAG anti-
body only) or overnight at 4 C (all other antibodies). Membranes
were washed four times and incubation with the appropriate
HRP-tagged secondary antibody was performed for 1 h at 4 C.
Following a final four 1xPBST washes, membranes were devel-
oped using SuperSignal West Femto kit (Thermo Fisher
Scientific). Images were acquired using Bio-Rad molecular im-
ager gel documentation system and displayed using Image Lab
(v. 4.0) analysis software (Bio-Rad, Hemel Hempstead, UK). Full
western blots are shown in Supplementary Material, Figure S5.
The following antibodies were used: Mouse monoclonal
anti-Reptin (Sigma –Aldrich SAB4200115, 1: 1000), Mouse mono-
clonal anti-Pontin (Sigma-Aldrich SAB4200194, 1: 1000), mouse
monoclonal anti-FLAG, Clone M2 (Sigma-Aldrich F9291, 1: 1000),
rabbit IFT88 polyclonal antibody (Proteintech 13967–1-AP, 1:
200), rabbit polyclonal anti-DNAAF1 (Sigma-Aldrich AV53359, 1:
100), mouse monoclonal “Living Colors” anti-GFP (Clontech
632380, 1: 1000). Rabbit polyclonal control IgG (Santa Cruz sc-
2027), goat anti-mouse HRP antibody (Dako, 1: 10000) and goat
anti-rabbit HRP antibody (Dako, 1: 10000).
Immunofluorescence and confocal microscopy
Human immortalized hTERT-RPE1 cells were grown in DMEM-
F12þ 10% FCS on coverslips in a 6–well plate until 70–80% con-
fluence. Transfection of SF-TAP-DNAAF1 constructs, with or
without eYFP-IFT88, was performed with Lipofectamine2000
(Thermo Fisher Scientific) in OptiMEM according to manufac-
turer’s protocols. After 4hr, media was changed for
DMEMF12þ 0.2% FCS and cells were grown for 48 h. Fixation
was either with ice-cold methanol (5 min at 20 C) or 2%[w/v]
para-formaldehyde (20min at room temperature, then permea-
bilised with 0.01%[v/v] Triton X-100 for 5 min at room tempera-
ture). Coverslips were blocked in 1% milk solution for at least
5min. Primary antibodies were made up in 1% milk solution and
incubated for at least 1 h. Coverslips were washed three times
in 1xPBS. Incubation with appropriate secondary antibodies in
1% milk solution was performed for 1 h. Following this, five PBS
washes were performed. Coverslips were set to slides in Mowiol
(Sigma-Aldrich).
Primary antibodies used were: mouse monoclonal anti-
Reptin (Sigma-Aldrich SAB4200115, 1: 200), Mouse monoclonal
anti-Pontin (Sigma-Aldrich SAB4200194, 1: 200), mouse mono-
clonal anti-FLAG, Clone M2 (Sigma-Aldrich F9291, 1: 500), rabbit
IFT88 polyclonal antibody (Proteintech 13967–1-AP, 1: 200), rab-
bit polyclonal anti-DNAAF1 (abcam ab75163, 1: 100), rabbit poly-
clonal anti-DNAAF1 (Sigma-Aldrich AV53359, 1: 100), guinea-pig
anti-RPGRIP1L (1: 500), mouse anti-gamma-tubulin (Sigma-
Aldrich, 1: 1000), mouse anti-centrin3 (Merck, 1: 100), goat anti-
gamma-tubulin (Santa-Cruz sc-7396, 1: 50), rabbit anti-ARL13B
(Proteintech, 1: 500) and mouse anti-acetylated a-tubulin
(Sigma-Aldrich, 1: 2000). Appropriate Alexa Fluor conjugated
secondary antibodies (Life Technologies) were utilized and DAPI
(1: 1000) was used for nuclear staining. Confocal images were
obtained using a Nikon A1R confocal microscope, processed by
NIS-Elements Confocal 4.5, (Nikon) software. ImageJ was used
for post-capture image processing of confocal .nd2 z-stack files.
Co-localizations were assessed using the Coloc2 plug-in, using
IFT88 staining in the green channel to define regions of interest.
siRNA knockdown
T47D cells were reverse transfected with 50 nM On-TargetPlus
siRNA smartpool oligos (Dharmacon) using Lipofectamine
RNAimax (Invitrogen). RNA isolation was performed using an
RNA isolation kit as per manufacturer’s directions (Qiagen).
mRNA probes for RUVBL1 and RUVBL2 were from Applied
Biosystems. Real time PCR was performed in triplicate using the
one-step RT-PCR kit and the 7500 system from Applied
Biosystems. siRNA knockdown in RPE1 cells was performed us-
ing 50 nM On-TargetPlus “SMARTpool” siRNA oligonucleotides
(Dharmacon), concurrently with DNAAF1 construct over-
expression using Lipofectamine2000 (Invitrogen), using meth-
ods as described above.
Mouse embryo whole mount in situ hybridisation
To produce an in situ hybridisation probe, a mouse Ruvbl1 cDNA
clone (MmCD00533571) was sourced from the DNASU Plasmid
Repository, Center for Eukaryotic Structural Genomics,
University of Wisconsin Madison, USA. This was linearized by
restriction digestion with ApaI (NEB). An anti-sense RNA probe
was synthesised using RNA DIG labelling mix (Roche) and T7
RNA polymerase (NEB). Wild-type C3H/HeH mouse embryos
were dissected in PBS at E7.5-E8.5, fixed in 4% PFA for 1 h,
washed 3 times in PBS and dehydrated through a methanol se-
ries after which they were stored at 20˚C. Following rehydra-
tion, whole-mount in situ hybridisation was performed
according to standard protocols. Post-hybridisation, DIG was de-
tected using anti-DIG alkaline phosphatase conjugated antibody
(Roche, 1; 500). Expression was visualised using NBT/BCIP
(Roche). Flat mounted embryos were photography using a Leica
MZ16.5 microscope.
Mouse embryo collection and immunofluorescence
Wild-type C57BL/6 mouse embryos at embryonic stages E7.0-
E8.5 were dissected in PBSþ 1% BSA. Fixation was performed in
4% para-formaldehyde for 1 h and then samples were washed in
three 1xPBS washes. Samples were dehydrated then rehydrated
in a series of methanol dilutions for 15min each, in increasing
then decreasing concentrations, respectively. Embryos were
washed in 1xPBS three times and blocked in 1% FCS for 1 h.
Primary antibody was diluted in 1% FCS and incubated with the
sample overnight at 4 C. Three 1xPBS washes preceded incuba-
tion with secondary antibody in 1% FCS for 1 h. Samples were
imaged using either light-sheet microscopy (on a Zeiss
Lightsheet Z1 instrument), or confocal microscopy (Nikon A1R)
for which the sample was mounted in Mowiol (Sigma-Aldrich).
Mouse monoclonal anti-Pontin (Sigma-Aldrich SAB4200194)
was used at 1: 200, with appropriate Alexa Fluor conjugated
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secondary antibodies (Life Technologies) and DAPI at 1: 1000 for
nuclear staining. Secondary antibody negative control staining
gave minimal background (data not shown).
Statistical analyses
Statistical analyses were preformed using InStat (GraphPad
Prism). Pairwise comparisons were analysed with Student’s
two-tailed t-test and one-way analysis of variance (ANOVA) was
used for three or more independent data-sets. Contingency ta-
bles were analysed with Pearson’s chi-squared test, using
two degrees of freedom. Results reported are from at least three
independent biological replicates. Error bars on bar graphs indi-
cate s.e.m. The statistical significance of pairwise comparisons
shown on bar graphs are indicated by: n.s., not significant,
*P< 0.05, **P< 0.01, ***P< 0.001, and ****P< 0.0001. For cell popula-
tions, a minimum of 150 cells were counted from 10 separate
fields of view. Normal distribution of data was confirmed using
the Kolmogorov-Smirnov test.
Supplementary Material
Supplementary Material is available at HMG online.
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